<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001281895</cik>
        <entityName>ROCKET PHARMACEUTICALS, INC.</entityName>
        <fileNumber>001-36829</fileNumber>
        <address>
            <street1>350 Fifth Avenue</street1>
            <street2>Suite 7530</street2>
            <city>New York</city>
            <stateOrCountryCode>NY</stateOrCountryCode>
            <stateOrCountry>NEW YORK</stateOrCountry>
            <zipCode>10118</zipCode>
        </address>
        <telephoneNumber>646-440-9100</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Warrant expires 9/2/2026</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(2)</ruleProvision>

    <signatureData>
        <signatureName>Jennifer Fainer</signatureName>
        <signatureTitle>CDO Analyst</signatureTitle>
        <signatureDate>2026-09-02</signatureDate>
    </signatureData>
</notificationOfRemoval>
